Synowledge Announces 15 New Customer Wins Worldwide
Stamford, CT, September 10, 2010 --(PR.com)-- Synowledge LLC, a market leader in drug safety and pharmacovigilance services and related IT solutions for life sciences organizations of all sizes announced its largest customer win growth to-date. Synowledge signs 15 new customers in 2010 (including a fortune 100 company and a top 20 pharma company). These new accounts outline Synowledge’s accelerating growth in its customer base and revenues.
Synowledge’s proven ability to provide its customers with quality services is evident in this double digit customer account growth. Synowledge’s growth in customer wins was spurred by the expansion of its global customer base - as well as Synowledge’s excellent service to existing customers.
In the past year, Synowledge has dramatically increased its customer base with a number of new customers, including a Fortune 100 company and a top 20 pharma company across the globe. In addition, existing Synowledge customers continued to upgrade and expand their usage of Synowledge solutions. Synwoledge’s strategic direction and customer-focused approach continue to drive the company's innovation and growth.
“Synowledge, backed by its strong expertise in drug safety, PV and IT solutions, continues to invest proactively in the strategic expansion of its solution suite. Our solutions continue to be chosen over those offered by some of the largest service providers in the industry,” said David Ingraham, Director, Marketing & Sales.
About Synowledge
Synowledge is a global provider of drug safety and pharmacovigilance services and related IT solutions to small, mid and large size pharmaceutical and biotechnology companies. Our comprehensive outsourcing solutions combine the unique strengths of both onshore and offshore services to meet all our clients’ needs. With more than 15 years of industry experience, our core team members have worked with leading pharmaceutical, biotech, medical device and health provider organizations. We have our headquarters located in Stamford CT, USA and additional offices in Bangalore, India and the United Kingdom. For more information, please visit www.synowledge.com.
###
Synowledge’s proven ability to provide its customers with quality services is evident in this double digit customer account growth. Synowledge’s growth in customer wins was spurred by the expansion of its global customer base - as well as Synowledge’s excellent service to existing customers.
In the past year, Synowledge has dramatically increased its customer base with a number of new customers, including a Fortune 100 company and a top 20 pharma company across the globe. In addition, existing Synowledge customers continued to upgrade and expand their usage of Synowledge solutions. Synwoledge’s strategic direction and customer-focused approach continue to drive the company's innovation and growth.
“Synowledge, backed by its strong expertise in drug safety, PV and IT solutions, continues to invest proactively in the strategic expansion of its solution suite. Our solutions continue to be chosen over those offered by some of the largest service providers in the industry,” said David Ingraham, Director, Marketing & Sales.
About Synowledge
Synowledge is a global provider of drug safety and pharmacovigilance services and related IT solutions to small, mid and large size pharmaceutical and biotechnology companies. Our comprehensive outsourcing solutions combine the unique strengths of both onshore and offshore services to meet all our clients’ needs. With more than 15 years of industry experience, our core team members have worked with leading pharmaceutical, biotech, medical device and health provider organizations. We have our headquarters located in Stamford CT, USA and additional offices in Bangalore, India and the United Kingdom. For more information, please visit www.synowledge.com.
###
Contact
Synowledge LLC
Nitin Malik
+91-80-22448841
www.synowledge.com
Nitin Malik
+91-80-22448841
www.synowledge.com
Contact
Categories